
With industry's onshoring tide rolling on, Amgen blueprints $900M expansion at Ohio biomanufacturing plant
After unveiling a new drug substance facility in North Carolina in December, Amgen is doubling down on expanding its U.S. production presence with plans for a major upgrade at its plant in central Ohio. The new project represents the latest in a string of …